Intelligent Document Processing to analyze current import entry documentation for potential discrepancies
Description
The intent is to assist in the process of discrepancy identification between documentation submitted by trade and CBP line data submitted.
Detailed example
List of discrepancies between document data and CBP line level information
AI / analytics pattern
Generative AI: AI that generates new or synthetic content (e.g., images, videos, audio, text, code).
Automation level / stage
a) Pre-deployment – The use case is in a development or acquisition status.
Expected benefit
By streamlining the manual document review process for standard entry documentation from trade, we can significantly reduce the time required for each line review, freeing up substantial analyst capacity to focus on high-risk shipments that pose greater threats to public health and safety. This efficiency improvement enables better resource allocation, reduces processing bottlenecks, and supports faster clearance times for compliant shipments while maintaining robust oversight. The enhanced operational efficiency directly supports FDA's core mission by enabling more targeted, risk-based resource deployment and improving both trade facilitation and import safety program integrity.
Controls / human review
ATO: Not reported; PIA: Not published